VitalStream™, Featuring Patented Pulse Decomposition Analysis™ technology becomes the World’s First Wireless Wearable Monitor for Continuous Blood Pressure and Advanced Hemodynamics – All with a single, easy-to-apply Finger Sensor

The most common intervention performed in hospitals is the measurement of vital signs.  While nurses are confident about their ability to gather and interpret the data needed to identify patients at risk of deterioration, there are concerns about the frequency of observation and at times the accuracy of vital sign measurements.

A continuous, wearable vitals monitor could transform this aspect of critical care, affording patients greater comfort and less stress, while providing their clinical team with accurate, real-time information from anywhere in the hospital. Nurses will be able to spend more time using their observational skills at the bedside, while doctors will be able to intervene sooner when signs of deterioration are detected.

As we will see, this is a far cry from the way vital signs monitoring is implemented today.

The application of continuous blood pressure monitoring has historically been limited to the intensive Care Unit (ICU) and Post-Anesthesia Care Unit (PACU), due to the cost and invasiveness of the equipment. However, the development of ICU grade wearable patient monitors is opening up opportunities to widen the use of continuous blood pressure monitors across the healthcare spectrum, bringing numerous benefits.

Among the many benefits being brought to the healthcare service by wireless patient monitoring is the facility to escalate home care for both chronic and acute conditions.

Physicians have long recognized the benefits of care at home but hospitals have been reluctant to send acute patients home because it would have impacted on their revenue under the fee-for-service model. Now that the Centers for Medicare & Medicaid Services (CMS) have removed that obstacle by introducing the Acute Hospital Care At Home waiver, the road is clear for home care to grow apace. And wireless patient monitoring is making it possible.

As new variants of the COVID-19 virus continue to pile pressure on already strained health services around the world, what hope is there for the future of medicine? With an ageing global population and a growing shortage of medical professionals, how can the healthcare industry get on top of the burgeoning workload to create breathing space for medical practitioners and better outcomes for all patients?

Hope lies with digital technology. While front line medicine and cutting-edge technology have always gone hand in hand, there remains considerable capacity for healthcare in general to reap the benefits of digital. The technology exists to greatly increase the capacity, inclusivity, accuracy, speed, efficiency, personalization and ultimately the outcomes of healthcare. The question is, how quickly can we bring it to bear?

Wireless monitors like VitalStream™ can help to drive down the cost of chronic disease management and deliver better patient outcomes.

Chronic disease management (CDM) is one of biggest challenges facing global health. Chronic conditions such as heart disease and diabetes are the leading cause of mortality in the developed world by far, and across the world they are projected to account for 69% of deaths by 2030.

Medical practitioners know that even a brief hypotensive event can harm a patient. This is why the ICU employs continuous hemodynamic monitoring to catch the earliest signs of such events and enable prompt intervention.

However, studies have found that post-operative patients returning to the general ward are still at risk of acute hypotensive events leading to cardiac arrest, and a high proportion of such events are not picked up. This highlights the need for continuous hemodynamic monitoring beyond the critical care wards, a need that can be met by wireless hemodynamic monitoring.

MedTech Innovator, the largest accelerator of medical devices in the world, announced that Caretaker Medical have been selected among five finalists out of 1,100 applicants to compete for the title of MedTech Innovator 2021.

“Every year I am more impressed by the caliber of companies that take part in our Accelerator and Showcase programs,” said Paul Grand. “This year’s five finalist companies are developing products that have the ability to really shake up the industry and provide significant value to patients. We are thrilled to be back in-person for our final competition at the conference and we know the live audience will have an extremely tough decision deciding this year’s winner.” Read more about the competition here or learn more about us today.

We are excited to announce the U.S. Food and Drug Administration (FDA) clearance of the company’s next-generation VitalStream™ wireless blood pressure and hemodynamic monitoring platform.